Medical device expertise Blur combines design, engineering, and ISO 13485 compliant contract manufacturing under one roof, signaling a strong capability to bring complex medical devices from concept to production, which can be leveraged to upsell end-to-end development services to OEMs and startups.

In-house labs With an in-house prototyping and test lab, machine shop, and human factors lab, Blur can shorten development cycles and offer rapid iteration capabilities, presenting an opportunity to position as a preferred partner for time-sensitive regulatory filings and FDA submissions.

Full service depth End-to-end offerings across industrial design, mechanical, electrical, software engineering and regulatory support enables Blur to target manufacturers seeking integrated teams, reducing coordination risk and procurement challenges for new medical device programs.

Mid-market scale Revenue in the 10-25M range and a lean to mid-size employee base suggest Blur can compete with boutique design houses while offering scalable manufacturing, making it a compelling candidate for startups maturing toward commercialization and OEMs seeking agile partners.

Strategic alignment Blur’s experience with large OEMs and startups, plus familiarity with FDA submissions and manufacturing constraints, positions the company to tailor offerings around regulatory-compliant development programs and production readiness improvements for devices approaching market entry.